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Commentary: Medication adherence early after stroke: using the Perceptions 
and Practicalities framework to explore stroke survivors’, informal carers’ and 
nurses’ experiences of barriers and solutions 
 
Medication nonadherence is a global public health problem (Costa et al, 2015). 
Approximately, one-third of stroke patients do not adequately take secondary 
prevention medication thereby increasing the risk of poor stroke outcomes (Al Alshaikh 
et al., 2016). A recent review of qualitative studies identified factors that may contribute 
or prevent medication adherence but found there were very few studies that focused 
on the period early after stroke, particularly between hospital and post-discharge 
(Gibson et al., 2020). The current study builds on this qualitative evidence by exploring 
the views and experiences of medication adherence in patients less than two-months 
after stroke onset using the Perceptions and Practicalities Approach (PAPA) 
framework. This framework uses both intentional and unintentional perceptual and 
practical factors to medication adherence, which is the approach recommended by the 
NICE Medicines Adherence Guidelines (2009).  
 
The strength of this qualitative study is that it considers the views of stroke patients, 
carers and stroke unit nurses to provide better understanding about medication 
adherence early after stroke. The findings are consistent with previous studies that 
identified barriers and facilitators of adherence, such as the stroke patients’ mood, 
motivation, the perceived value of taking medications and trust in healthcare providers 
(Al Alshaikh et al., 2016; Jamieson et al., 2017; Gibson et al., 2020). The carers 
included in the study highlighted the unique challenges of being the stroke patient’s 
advocate as well as managing medications after hospital discharge. Education and 
support are seen as vital to assist adherence, but delivery was described as variable 
and stroke nurses’ expertise was felt to be under-utilised. Unsurprisingly, the practical 
barriers include stroke patients’ physical and cognitive capabilities as well as 
organisational factors, such as polypharmacy, complex medication schedules and lack 
of support with medication management. The obvious limitation of this study is the 
small sample size from a single centre, which may not be generalisable or 
transferrable to other settings. However, the benefit of using a qualitative approach 
that utilises the PAPA framework is that it provides deeper insights into the participants 
perceptions and practicalities of secondary stroke prevention medication adherence. 
Overall, the study findings emphasise the need for novel interventions that address 
not only the practical barriers, but also the perceptions and beliefs of patients that may 
affect whether they take the medications or not early after stroke. It also highlights the 
importance of shared decision-making between the stroke patients, carers and the 
multi-disciplinary team (National Institute for Health and Care Excellence, 2009). 
However, further research is required to evaluate the efficacy of novel integrated care 
strategies, including supportive self-management, to improve secondary medication 
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